跳至主要内容
临床试验/CTRI/2024/04/066548
CTRI/2024/04/066548尚未招募不适用

Prevalence of Alloantibodies in Transfusion dependent Thalassemia patients

Sunil Kumar1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2024年5月10日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
90
试验地点
1
主要终点
To study the frequency of alloimmunization in patients diagnosed with thalassemia dependent on regular blood transfusions.

研究概览

简要总结

The present study is a retrospective study where secondary data obtained from previous laboratory records of patients diagnosed with thalassemia, receiving regular blood transfusions at Lok Nayak Hospital during the study period from 1 November 2023- 31 January 2024 will be analysed. The patients had been admitted for receiving blood transfusion. Blood samples had been collected immediately prior to the transfusion. These samples had been subjected to antibody screening. Plasma samples had been screened for alloantibodies by the indirect antiglobulin test utilizing commercial three cell panel, Diacell I+II+III. Plasma samples that had exhibited a positive result with ID-Diacell antibody screen underwent antibody identification utilizing an extended commercial 11-cell identification panel.

研究设计

研究类型
Observational

入排标准

年龄范围
1.00 Day(s) 至 99.00 Year(s)(—)
性别
All

入选标准

  • Patients diagnosed with thalassemia dependent on regular blood transfusion.

排除标准

  • Patients diagnosed with thalassemia not dependent on regular blood transfusion.

结局指标

主要结局

To study the frequency of alloimmunization in patients diagnosed with thalassemia dependent on regular blood transfusions.

时间窗: At baseline

次要结局

  • To correlate the frequency of alloimmunization in transfusion dependent thalassemia patients with the red blood cell requirement(At baseline)

研究者

发起方
Sunil Kumar
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Sunil Kumar

Lok Nayak Hospital

研究点 (1)

Loading locations...

相似试验